Imbruvica 140mg Capsule

About this Medicine

Imbruvica 140mg Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy. Imbruvica 140mg Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. It may cause headache, diarrhea, and nausea as its side effects. Consult your doctor in case any of these side effects persist or get worse.There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.

How it Works

Imbruvica 140mg Capsule is a Bruton's tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.

Key Facts

Chemical Class :: Diphenylethers Derivative|Habit Forming :: No|Therapeutic Class :: ANTI NEOPLASTICS|Action Class :: Bruton's tyrosine kinase (BTK) inhibitors

Safety Overview